Companies / Immix Biopharma, Inc.

Immix Biopharma, Inc.

Nasdaq: IMMXCIK 1873835LOS ANGELES, CA

Financials · FY2023

Revenue$20.00M
Net income$-29.44M
Total debt—
Cash$225.49M
Diluted EPS$-0.89
Shares outstanding71.5M

Ownership

71.5M shares outstanding · as of Aug 3, 2026
0.64%Insiders
Ownership
Insiders0.64%456,895
Institutions44.09%31,540,513
Public float55.27%39,541,906

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Chang Nancy TDirector
0.60%428,190
Buchan JaneDirector
0.04%28,705

Institutional holders 74

View all →
HolderValue% of shares
Janus Henderson Group PLC$43.70M6.71%
State Street Corporation$30.90M4.19%
BlackRock, Inc.$30.83M4.18%
Millennium Management LLC$15.94M2.45%
Saturn V Capital Management LP$15.69M4.19%
Marshall Wace, LLP$14.95M2.29%
Eventide Asset Management, LLC$13.33M3.56%
Adage Capital Partners Gp, L.L.C.$7.84M2.10%
Vanguard Group Inc$5.73M1.53%
Bleichroeder LP$5.23M1.40%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 22, 2026Buchan Jane
Director
GrantCommon Stock$0+6K
+27.83%
28,705
0.04% of shares
low
May 22, 2026Chang Nancy T
Director
GrantCommon Stock$0+6K
+1.48%
428,190
0.60% of shares
low
May 22, 2026Buchan Jane
Director
GrantStock Option (Right to Buy)—+13K
12,500
0.02% of shares
low
May 22, 2026Chang Nancy T
Director
GrantStock Option (Right to Buy)—+13K
12,500
0.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Millennium Management LLCPassive13G———
Janus Henderson Group PLCPassive13G———
Saturn V Capital Management LPPassive13G———
Millennium Management LLCPassive13G/A———
Janus Henderson Group PLCPassive13G/A———
Janus Henderson Group PLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IMMX——45258H106—